Quipt Home Medical Corp. (QIPT)
Data as of , from SEC Form 4 filings.
See up to 3 months of QIPT. The 7-day demo opens the 1M and 3M ranges and puts QIPT on your watchlist.
Start 7-day demoLatest QIPT insider trades
About Quipt Home Medical Corp. (QIPT)
Quipt Home Medical Corp. files with the SEC under CIK 0001540013 and is classified as misc health and allied services, nec. We track it alongside the rest of the Health Care sector.
QIPT Form 4 activity by transaction type, last 90 days
No Form 4 activity for QIPT in the last 90 days.
QIPT insider transactions (Form 4)
3010 Form 4 filings on record, the earliest from Dec 30, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Brian Joseph Wessel - Director | Derivative | Common Shares | 116,854 footnote F2 | $3.65 | $427K | |
| Brian Joseph Wessel - Director | Derivative | Common Shares | 98,875 | $3.65 | $361K | |
| Brian Joseph Wessel - Director | Derivative | Stock Option (Right to Buy) | 75,000 | - footnote F4 | - | |
| ||||||
| Thomas Roehrig - Officer | Derivative | Common Shares | 173,000 footnote F2 | $3.65 | $631K | |
| Thomas Roehrig - Officer | Derivative | Stock Options (Right to Buy) | 50,000 | - footnote F3 | - | |
| Thomas Roehrig - Officer | Derivative | Stock Options (Right to Buy) | 50,000 | - footnote F3 | - | |
| Thomas Roehrig - Officer | Derivative | Stock Options (Right to Buy) | 30,000 | - footnote F3 | - | |
| ||||||
| Mark Alan Miles - Officer | Derivative | Common Shares | 110,000 footnote F2 | $3.65 | $402K | |
| Mark Alan Miles - Officer | Derivative | Stock Option (Right to Buy) | 12,500 | - footnote F3 | - | |
| Mark Alan Miles - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - footnote F3 | - | |
| Mark Alan Miles - Officer | Derivative | Stock Option (Right to Buy) | 15,000 | - footnote F3 | - | |
| ||||||
| Mark Alan Greenberg - Director | Derivative | Common Shares | 435,457 footnote F2 | $3.65 | $1.59M | |
| Mark Alan Greenberg - Director | Derivative | Stock Option (Right to Buy) | 428,750 | - footnote F3 | - | |
| Mark Alan Greenberg - Director | Derivative | Stock Option (Right to Buy) | 60,000 | - footnote F3 | - | |
| ||||||
| Patrick Dennis Gamble - Officer | Derivative | Common Shares | 60,057 footnote F2 | $3.65 | $219K | |
| Patrick Dennis Gamble - Officer | Derivative | Stock Option (Right to Buy) | 15,000 | - footnote F3 | - | |
| ||||||
| Gregory John Crawford - Officer | Derivative | Common Shares | 3,351,196 footnote F2 | $3.65 | $12.23M | |
| Gregory John Crawford - Officer | Derivative | Common Shares | 22,500 | $3.65 | $82K | |
| Gregory John Crawford - Officer | Derivative | Common Shares | 1,216,832 | $3.65 | $4.44M | |
| Gregory John Crawford - Officer | Derivative | Stock Option (Right to Buy) | 75,000 | - footnote F4 | - | |
| ||||||
| Kevin A. Carter - Director | Derivative | Common Shares | 201,160 footnote F2 | $3.65 | $734K | |
| Kevin A. Carter - Director | Derivative | Stock Option (Right to Buy) | 5,625 | - footnote F3 | - | |
| ||||||
| David Bachelder - Officer | Derivative | Common Shares | 22,156 footnote F2 | $3.65 | $81K | |
| David Bachelder - Officer | Derivative | Stock Option (Right to Buy) | 50,000 | - footnote F3 | - | |
| David Bachelder - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - footnote F3 | - | |
| ||||||
| Hardik Mehta - Officer | Derivative | Common Shares | 366,471 footnote F2 | $3.65 | $1.34M | |
| Hardik Mehta - Officer | Derivative | Common Shares | 884,199 | $3.65 | $3.23M | |
| Hardik Mehta - Officer | Derivative | Stock Option (Right to Buy) | 60,000 | - footnote F4 | - | |
| ||||||
| Patrick Dennis Gamble - Officer | Open-market purchase | Common Shares | 7,000 | $2.42 | $17K | |
| Patrick Dennis Gamble - Officer | Open-market purchase | Common Shares | 10,000 | $2.47 | $25K | |
QIPT insider trading FAQ
What is the latest insider trade for QIPT?
Quipt Home Medical Corp. (QIPT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-16. The full record for QIPT runs to 10 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying QIPT stock?
No insider purchases of QIPT were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling QIPT stock?
No insider sales of QIPT were filed in the last 90 days.
Where can I see QIPT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects QIPT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brian Joseph Wessel view on EDGAR
- - Thomas Roehrig view on EDGAR
- - Mark Alan Miles view on EDGAR
- - Mark Alan Greenberg view on EDGAR
- - Patrick Dennis Gamble view on EDGAR
- - Gregory John Crawford view on EDGAR
- - Kevin A. Carter view on EDGAR
- - David Bachelder view on EDGAR
- - Hardik Mehta view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where QIPT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow QIPT with a 7-day demo
- QIPT on your watchlist
- Every QIPT Form 4 filing on record
- Up to 3 months of QIPT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive